One Sentence Summary: Maternal smoking during pregnancy alters the expression of genes within the developing human cortex and these changes are enriched for genes implicated in neuropsychiatric disorders.
Introduction
Cigarette smoking and nicotine addiction continue to be major public health problems, due to their established association with increased risk of cancer, respiratory disease, and many other disease outcomes in adults (1) . Cigarette smoking exposure also is highly deleterious to fetal development, having been associated with heightened risk of intrauterine growth restriction and low birth weight (2) . There is accumulating evidence that in utero exposure to nicotine and other elements of cigarette smoking is associated with a greater risk of the subsequent development of mental illnesses (3, 4) . Despite the well-known adverse effects of smoking on the smoker and the fetus carried by mothers who smoke, little is known about the effects of smoking on gene expression in the adult and especially the fetal brain.
In the United States, 8.4% of pregnant women smoke while pregnant (5) . Smoking during pregnancy has been repeatedly associated with a host of adverse health outcomes for the infant including premature birth, low birth weight, stillbirth, and mortality (6) . Maternal smoking during pregnancy poses a potent danger to the developing human brain because many components of cigarette smoke, including nicotine, have neuroteratogenic effects (7) . There is mixed evidence for maternal smoking during pregnancy as a risk factor for neuropsychiatric disorders including schizophrenia (3, 4) , attention-deficit / hyperactivity disorder (8) (9) (10) (11) (12) , Tourette syndrome (12, 13) , impaired cognitive development (14, 15) , obsessive-compulsive disorder (12) , and autism spectrum disorder (16) .
The molecular mechanisms underlying risk for neuropsychiatric disease from maternal smoking during pregnancy remains elusive. Previous studies have found epigenetic changes in cord blood (17, 18) and differential gene expression in placental tissue (19) . However, only one prior study has directly examined associations of maternal smoking during pregnancy with Page 4 of 36 epigenetic changes in the prenatal human brain (20) , and no study, to our knowledge, has characterized transcriptional changes in the prenatal brain. Characterizing the gene regulatory changes associated with smoking exposure in prenatal life may identify potential mechanisms related to disease risks later in life especially with regard to neuropsychiatric disorders. We can better understand the link between maternal smoking during pregnancy and future behavioral and cognitive sequelae by directly studying molecular changes in prenatal human cortical tissue exposed to cigarette smoke.
To characterize molecular changes in the developing prenatal brain associated with in utero smoking exposure, we analyzed RNA-seq data from post-mortem fetal human prefrontal cortex tissue. We found much greater gene dysregulation within the smoking-exposed prenatal brain than the exposed adult brain. Interestingly, the significant differentially expressed prenatal genes included GABRA4, NRCAM, and KCNN2 which have all been previously implicated in addiction (21) (22) (23) (24) . Moreover, genes differentially expressed in the prenatal brain and genes showing different responses to smoking exposure across the lifespan were enriched for autism spectrum disorder (ASD) genes and related intellectual impairment genes. Neuropsychiatric disorders associated with maternal smoking have extensive comorbidity with substance abuse and the differential expression associated with maternal smoking may partly explain the molecular biology that underlies the comorbidity (25) . These results highlight dysregulation of the developing prenatal brain's transcriptome associated with in utero smoking exposure and putative mechanisms of risk for neurodevelopmental disorders later in life.
Results
We used polyA+ RNA-seq data from 207 adult, non-psychiatric and 33 prenatal postmortem brain samples with cotinine (a nicotine metabolite) or nicotine toxicology test results available to investigate transcriptomic changes associated with cigarette smoking exposure ( Supplemental Table S1 ). Nicotine or cotinine detectability (>5 ng/mL nicotine or >10 ng/mL cotinine) was closely coupled to a case records and/or next-of-kin reported history of smoking in the proband: 87% of adult controls with nicotine/cotinine detected also had a history of smoking reported (7 samples had positive toxicology without a reported history of smoking). We did not observe significant differences in cotinine concentrations between adult active smokers with a positive next of kin history of smoking versus active smokers without a positive history (mean +history =279 ng/mL, N +history =39; mean -history =208 ng/mL, N -history =7; p=0.444) or nicotine concentrations in blood (mean +history =41.0 ng/mL, N +history =32; mean -history =39.8 ng/mL, Nhistory =6; p=0.936). These results suggest that the cotinine and nicotine biomarkers successfully capture the smoking-exposed phenotype.
Cigarette smoking in adults was weakly associated with increased RNA Integrity Number (RIN; p=0.052) and brain bank (p=0.024), but in the prenatal cohort smoking exposure was not associated with either RIN (p=0.76) or brain bank (p=1, Supplemental Table S1 ). No differences were observed at p<0.05 between the adult smoking and non-smoking groups with regards to age, ancestry, sex, or other measures of RNA quality (Supplemental Fig. S1A ). In the prenatal cohort, there were trends for smoking exposure to be associated with greater gestational age (p=0.084) and higher mitochondrial mapping rate (p=0.063) (Supplemental Fig. S1B ). These analyses suggest RNA quality is mildly associated with cigarette smoke exposure, a confound we sought to mitigate by adjusting for explicit measures of RNA quality and constructed surrogate variables (SVs). After filtering out lowly expressed features, 18,067 genes, 189,292 exons, 137,016 exon-exon splice junctions, and 275,885 expressed regions (ERs) (26) were tested for differential expression, adjusting for age, sex, ancestry, RNA quality, and latent confounds in the pre-and post-natal cohorts (see methods for details).
Gene expression changes associated with smoking exposure in the developing brain
We performed differential expression analysis of genes and their transcript features comparing dorsolateral prefrontal cortex (DLPFC) tissue from 16 smoking-exposed compared to 17 smoking-unexposed prenatal samples. After correcting for multiple testing (FDR<10%), 14
prenatal genes had evidence of differential expression (DE), mostly at the gene level (Table 1, median absolute log 2 fold change [LFC] = 0.618). Some of these differentially expressed genes are potentially related to nicotine dependence or addiction more broadly: KCNN2, GABRA4, and NRCAM ( Figure 1A -C). The most significantly differentially expressed transcript feature at the gene level was KCNN2 which encodes a small-conductance Ca 2+ -activated K + channel ( Figure   1A , p=2.60×10 -6 , LFC = -0.694). GABRA4, a gene coding for the alpha-4 subunit of the GABA receptor, was also differentially expressed ( Figure 1B , p=1.86×10 -5 , LFC = 1.06). NRCAM, a gene encoding neuronal cell adhesion molecule, was differentially expressed at the gene level ( Figure 1C , p=7.17×10 -5 , LFC = -0.568) and six previously annotated NRCAM exon-exon splice junctions were also differentially expressed (p min =2.29×10 -7 , LFC p-min = -0.689, Supplemental   Table S2 ). Thus, prenatal smoking exposure is associated with changes in the expression of some genes previously associated with addiction in the literature.
Other differentially expressed genes between the exposed and unexposed prenatal groups play a role in neurodevelopment and may be linked to neuropsychiatric disorders: CNTN4, EPHA8, and PCDH10 ( Figure 1D -F). Contactin 4 (CNTN4, Figure 1D , p=2.79×10 -5 , LFC=0.682) is a cell adhesion molecule involved in synaptic formation (27) . The association with PCDH10 was in a differentially expressed region ( Figure 1E , p=9.45×10 -8 , LFC= -1.37, chr4:134,116,962-134,116,976), a 15 base pair strictly intronic region. Protocadherin-10 (PCDH10) encodes a cell adhesion molecule involved in synaptic elimination (28) . EPH Receptor A8 (EPHA8, Figure 1F , p=7.49×10 -6 , LFC=1.55) encodes a member of the Eph family of tyrosine protein kinase receptors, which has a functional role in axonal pathfinding during neurodevelopment (29) . A gene-level, subgroup analysis of the significant differentially expressed genes which used only African-American prenatal samples (N=30) generated effect sizes consistent with those from the original model which included 3 Caucasian smokingexposed prenatal samples (r=0.99, p=1.18×10 -10 , Supplemental Fig. S2 ). These findings suggest, perhaps not surprisingly, that genes involved in neurodevelopment may be disrupted by prenatal exposure to cigarette smoke, a putative neurodevelopmental insult.
More subtle gene expression changes associated with smoking exposure in the adult brain
In the adult sample, only two genes were differentially expressed between active smoker (N=150) and non-smoker groups (N=57; Table 1 ). MARCO, an immune gene, was the most significantly differentially expressed gene among adults (Figure 2A ; p=4.67×10 -9 , LFC = -0.568). In an independent cohort of DLPFC tissue from 107 patients with schizophrenia (65 active smokers, 42 non-smokers), MARCO was similarly differentially expressed (p=3.28×10 -5 , LFC = -1.34, Figure 2B ). To assess the robustness of our model, we then stratified adult smokers into three categories: non-smokers (N=150), light-smokers (N=23), and heavy smokers (N=23), based on cotinine levels (200 ng/mL heavy-light threshold). Under this ordinal sensitivity model,
MARCO remained significantly differentially expressed (p=6.16×10 -10 , LFC=-1.211, Figure 2C ), and our global results were highly correlated across all transcript feature levels confirming the robustness of our analysis (Supplemental Fig. S3 ). An exon-exon splice junction mapping to four transcripts of CEP85 (chr1:26,595,127-26,595,950) was also differentially expressed between adult smokers and non-smokers (p=4.46×10 -7 , LFC = -0.25), but this association did not replicate in our independent schizophrenia cohort (p=0.47; Supplemental Fig. S4 ). Together, these findings indicate cigarette smoke exposure has subtler effects on the adult prefrontal cortex's transcriptome than on the developing brain, despite having the larger sample size compared with the fetal sample.
Significant changes in susceptibility to smoking exposure across development
After observing non-overlapping genes within the differentially expressed transcript features across the adult and prenatal cohorts associated with smoking exposure, we performed an interaction analysis to more formally determine the potentially age-dependent effects of smoking exposure in prenatal versus adult samples. While the significant main effects of smoking exposure in adulthood were limited to MARCO and the CEP85 junction described above, there were 5,293 differentially expressed features corresponding to 1,315 unique Ensembl genes ( Supplemental Table S3 ) associated with the interaction between developmental stage (pre-versus post-natal) and smoking exposure after adjusting for possible technical and biological confounds (FDR<10%). The different feature types offered both unique and convergent evidence for genes implicated as interaction genes (i.e., genes that respond differently to cigarette smoking in prenatal vs. adult cortical tissue), suggesting transcript-feature level analysis beyond the gene-level summary generates additional valuable insight into changes in the transcriptomic landscape. For instance, 87 genes were shared as significant interaction genes across all feature types, but 315 genes were solely significant for an interaction effect at the exon-level summarization ( Figure 3 ).
We next asked whether smoking exposure's differential effects on gene expression across the lifespan are mostly driven by significant changes in the prenatal cortical transcriptome, hypothesizing that the prenatal cortical transcriptome is more pliable than the adult one. Post-hoc analysis confirmed that more of these transcript features with a significant interaction were nominally differentially expressed (p<0.05) by smoking exposure condition in prenatal cortex (N=1,850, 35.0%) than in adult cortex (N=585, 11.1%; p=1.40×10 -8 ). These findings underscore that smoking exposure exerts different effects on gene expression across the human lifespan and these effects occur more frequently in the prenatal cortex.
Enrichment of interaction genes in diverse processes and neurodevelopmental disorders
To explore the potential functional implications of the 1,315 genes with differential effects of cigarette smoke exposure in prenatal and adult life, we performed gene ontology and pathway analyses with the sets of unique genes tagged by differentially expressed age-dependent transcript features: genes (N=752), exons (N=746), junctions (N=257), and ERs (N=285). We performed separate and convergent transcript feature level gene ontology analysis and uncovered significant enrichment of biological categories across all ontologies tested ( Supplemental Table   S4 ).
Here, "nicotine addiction" (hsa04080, p=2.04×10 -7 , q=3.15×10 -5 ) was one of the most significantly enriched KEGG categories across multiple feature summarizations. Other top KEGG categories included "retrograde endocannabinoid signaling" (hsa04723, p=2.04×10 -7 , q=3.15×10 -5 ) and "neuroactive ligand-receptor interaction" (hsa05033, p=2.04×10 -7 , q=3.15×10 -Page 10 of 36 5 ). The most significantly enriched biological processes involved "behavior" (GO:0007610, p=2.33×10 -10 , q=9.87×10 -7 ), "positive regulation of nervous system development" (GO:0051962, p=1.31×10 -7 , q=2.32×10 -4 ), and "synapse organization" (GO:0050808, p=2.84×10 -7 , q=2.57×10 -4 Supplemental Table S5A ).
We further observed enrichment of significant age-dependent interaction genes across multiple autism gene sets including SFARI Gene (p=7.20×10 -8 ), AutDb (p=1.17×10 -7 ), and the curated non-syndromic ASD gene database set (p=3.77×10 -4 , Supplemental Table S5B ). Interaction genes were also significantly enriched for schizophrenia genes implicated from single nucleotide variant (SNV) studies (p=0.00136) as well as nominally significantly enriched for intellectual disability genes (p=0.0115) and syndromic neurodevelopmental disorder (NDD) genes (p=0.0175; Supplemental Table S5B ). The enriched NDD (N=6) were a subset of the enriched ASD genes, but the enriched schizophrenia SNV and intellectual disability genes were mostly distinct (Supplemental Fig. S5 ). Therefore, genes affected differently by cigarette smoke exposure across the lifespan appear enriched in autism spectrum disorder and other neuropsychiatric disorders gene sets.
Smoking exposure's transcriptomic pattern is similar to post-mortem brain ASD case-control differences Next, to more fully interrogate these genes in ASD, we performed gene set enrichment analysis in post-mortem human brain tissue from a public database of patients with ASD compared to unaffected controls (32) by comparing the gene expression differences from our significant differentially expressed prenatal and interaction genes against ASD-related gene expression differences ( Supplemental Table S6 , Supplemental Fig. S6A ). Our differentially expressed prenatal genes (N=14) were more highly ranked relative to other genes in terms of the ASD case-control differences in frontal cortex (BA9; p=1.35×10 -6 ) and temporal cortex (BA41-42-22; p=6.49×10 -5 ), but not vermis (p=0.646, Supplemental Fig. S6B ). Likewise, the interaction genes tested in this ASD data (N=1,293) also showed significant enrichment for ASD casecontrol differences in frontal cortex (p=3.45×10 -5 ) and temporal cortex (p=2.77×10 -9 ), but not vermis (p=0.963, Supplemental Fig. S6C ). We did not observe significant enrichment for schizophrenia case-control differences (33, 34) with either the differentially expressed prenatal genes (p=0.14) or the interaction genes (p=0.23). These findings suggest molecular changes in the developing human cortex associated with maternal smoking during pregnancy are analogous, at the transcriptomic scale, to the cortical pathology of ASD and these differences are, at least, partially selective.
Smoking-associated genes form protein-protein interaction networks
We investigated the properties of protein-protein interaction (PPI) networks (33) constructed from proteins encoded by genes differentially expressed in prenatal development and by genes exhibiting an age-dependent response to smoking exposure. Differentially expressed prenatal genes (N=14) and the 400 most significant interaction genes mapping to unique STRING identifiers (N=384) had more PPIs than anticipated (p<0.003), and the top interaction genes also had significant subnetworks (p<2.2×10 -16 ), Supplemental Fig. S7A-S7C ). Next, we explored subgroups of the interaction genes which were significantly enriched for 
Discussion
This study is the first, to our knowledge, to perform an extensive interrogation of the effect of smoking exposure on the prenatal cortical transcriptome. The prenatal brain is more sensitive to many environmental agents in both human and animal studies than the adult brain (34) (35) (36) and early neurodevelopmental exposure can associate with risk for neuropsychiatric disorders like autism, intellectual disability and schizophrenia later in life (37) . Therefore, one might expect signatures of smoking exposure would be more pronounced in the developing human brain. Consistent with this hypothesis, we found 14 genes differentially expressed in the prenatal cortex compared to only 2 genes in the adult cortex.
The transcriptomic effects of smoking exposure were more noticeable in the prenatal brain despite the smaller sample size available, underscoring the effects of maternal smoking on the prenatal human brain's sensitive developmental trajectory. Prenatal exposure to smoking was associated with changes in gene expression relevant to neurodevelopment and addiction which some studies have linked to maternal smoking during pregnancy (38) (39) (40) . NRCAM encodes a neuronal cell adhesion molecule, and expression was reduced within smoking-exposed prenatal brain. This difference may have downstream consequences, as neuronal cell adhesion molecules are involved in neurodevelopment (41) (42) (43) and have been linked to autism (44) (45) (46) and schizophrenia (47) (48) (49) . KCNN2 levels were also reduced in the smoking-exposed prenatal group.
KCNN2 encodes small conductance Ca 2+ -activated K + channels, and is part of a family of proteins that has been linked to substance abuse (23, 50).
One potential mechanism for smoking's neurodevelopmental effects is through mediating changes to the GABAergic signaling pathway: endogenous nicotinic acetylcholine receptor signaling plays a crucial role in neuronal development by driving the GABAergic shift from an excitatory to an inhibitory neurotransmitter (51) . Interestingly, GABRA4, a gene coding for the alpha-4 subunit of the GABA receptor, was previously associated with nicotine dependence in targeted studies (21, 52, 53) . We also found nominally significant differences between the prenatal brains by smoke exposure within key genes (CHRNA7, SLC12A5, and SLC12A2) mediating the GABAergic transition from excitatory to inhibitory. Moreover, several other genes involved in GABAergic signaling exhibited a different response to smoking exposure across development, some of which have been previously implicated in ASD. It is plausible, although highly speculative, that the presence of nicotine due to maternal smoking during pregnancy interferes with nicotinic cholinergic-GABAergic neurodevelopmental dynamics, thus generating future neuropsychiatric risk.
Smoking exposure was also associated with changes in prenatal expression of multiple genes important in neurodevelopment such as CNTN4 and EPHA8. Differentially expressed genes in the prenatal cohort were enriched in publicly available autism databases, and gene ontology analysis of the significant interaction genes (i.e., genes that were differentially expressed by smoking exposure in prenatal but not adult donors and vice versa) highlighted gene sets relevant to neurodevelopment such as synapse organization. Maternal smoking during pregnancy is associated with multiple adverse health outcomes for the offspring later in life (37, (54) (55) (56) (57) . These adverse outcomes include greater risk for substance abuse in adolescence which may be partially mediated via changes to the epigenetic landscape (58) . Our findings add orthogonal molecular support to the hypothesis that maternal smoking during pregnancy may be a risk factor for neuropsychiatric disease later in life, especially for ASD.
Regardless of age, differentially expressed genes between the smoking exposed and unexposed donors could also relate to other hazardous chemicals besides nicotine, indirect effects of cigarette smoke exposure, and residual confounding by unmeasured factors associated with smoking. For example, cigarette smoke contains over 500 distinct chemicals of which 98 have been deemed dangerous to human health (59) and the molecular correlates of these compounds in human brain range in characterization. The genes identified in this study as differentially expressed by smoking exposure include ones that predispose to cigarette smoking susceptibility and ones that are altered by smoking or other related exposures. Nonetheless, these differentially expressed genes highlight biologically important genes and pathways that represent smoking-related changes in the brain.
Our results in DLPFC may not translate to the effects of smoking in other brain regions, as the effects of cigarette smoke exposure on the developing human cortex may vary across brain regions which have distinct cell type compositions and unique molecular profiles (60) . In summary, we performed transcriptome-wide scans to search for disturbances in gene expression associated with in utero smoking exposure. The effect of smoking exposure on gene expression was much more prominent in the developing prenatal brain than the mature adult brain. Disrupted neurodevelopment due to early environmental insults confers risk for neuropsychiatric disorders later in life, and indeed maternal smoking during pregnancy has been suggested as a risk factor for neuropsychiatric disorders in affected offspring (3, 4) . Our study provides molecular evidence that maternal smoking during pregnancy may disrupt pathways relevant in neurodevelopment, which may influence risk of neuropsychiatric or other disease outcomes in the offspring. By characterizing transcriptomic effects of maternal smoking upon the human prenatal cortex, we have added evidence for maternal smoking as a risk factor for neuropsychiatric disease. Overall, these findings offer new molecular clues into how in utero smoking exposure can disrupt human cortex development and increase risk for the development of neuropsychiatric disorders in the offspring.
Materials and Methods

Defining smoking exposure
Presence or absence of nicotine and cotinine was determined by LC/MS-MS measurement in blood and/or cerebellar brain tissue for postnatal samples by National Medical Services (www.nmslabs.com). For prenatal samples, nicotine, cotinine, and OH-cotinine were measured by LC/MS-MS in cerebellar brain tissue as previously described (62) . We restricted the adult cohort to non-psychiatric control samples over the age of 16 at time of death with toxicology information (N=207). "Non-smokers" (N=150) lacked detectable levels of nicotine (<5 ng/mL) and cotinine (<10 ng/mL) in blood and/or cerebellum, and did not have a history of current smoking as reported by next of kin. "Smokers" had detectable levels (>5 ng/mL nicotine or >10 ng/mL cotinine; Supplemental Fig. S8A-B ) of nicotine or cotinine in blood or brain (N=57). The prenatal cohort was limited to samples before birth with toxicology information (N=33). Within the prenatal cohort, we defined "smoking-exposed" (N=16) based on having either a self-reported maternal history of sustained smoking during pregnancy or detectable levels of cotinine in brain, and "smoking-unexposed" (N=17) based on having no maternal smoking history and no detectable levels of nicotine or cotinine.
RNA sequencing data
We used samples described in Jaffe el al. (63) , which, briefly, were aligned to the genome and transcriptome using TopHat2 (64) and quantified to Ensembl v75. We used four convergent measurements of expression ("feature summarizations") (65, 66): (1) gene and (2) exon counts that rely on existing gene annotation, and two annotation-agnostic approaches calculated from the read alignments -(3) read coverage supporting exon-exon splice junctions (e.g. coordinates of potentially intronic sequence that are spliced out of mature transcripts captured by a single read) and (4) read coverage overlapping each base in each sample which we have summarized into contiguous "expressed regions" (ERs) (26) .
Quality control and data processing
To identify and characterize potential confounders and relationships between cigarette smoking and other variables, we tested the associations between clinical and RNA quality metrics using descriptive statistics, t-tests, Fisher's exact test, and ANOVA. Genes with mean RPKM of less than 0.1 were considered negligibly expressed and were filtered out, the gene RPKM was then transformed (log 2 (RPKM)+1) and used for principal components analysis. The association of the top five expression principle components (PCs) with clinical variables and RNA quality measures was assessed using Pearson correlations and t-tests. Samples were sequentially plotted in the first five PC spaces and these plots were inspected for the presence of outliers (0 outliers, Supplemental Fig. S9A-B ). Multidimensional scaling (MDS) was performed on autosomal LD-independent genetic variants to construct genomic ancestry components on each sample, which can be interpreted as quantitative levels of ancestry -the first component separated the Caucasian and African American samples (for further details on MDS construction see Jaffe et al.) (67) . Outlier samples (3 adult non-smokers; 2 prenatal smoking-exposed) on the first five ancestry components were dropped (Supplemental Fig. S10A-B ). We calculated surrogate variables (SVs) using the sva Bioconductor package (68) and included them as covariates to adjust for latent confounds.
We retained genes, exons, and junctions with 10% or more samples having at least 1 count per million (cpm) that were at least partially annotated. Expressed regions (ERs;
N=275,885) were defined by contiguous sequences with mean library-size normalized coverage > 5 reads per 80 million (26) .
Differential gene expression analyses
All features were tested under an empirical Bayes framework for significant differential expression between smoker and non-smoker adult samples, or between smoking-exposed and unexposed prenatal samples, using the moderated t-test implemented in the limma Bioconductor package (69 
Sensitivity analysis for smoker definitions
A sensitivity analysis was performed in our adult cohort to ascertain the robustness of results to the definition of smoker. Adult smokers with blood-based cotinine information (N=46)
were stratified into light smokers (cotinine blood concentration < 200 ng/mL; N=23) and heavy smokers (cotinine blood concentration ≥ 200 ng/mL; N=23) with the threshold based on evidence from the literature (70) (71) (72) and also being near the median cotinine blood concentration among our samples (median concentration = 205ng/mL, Supplemental Fig. S8A ). Non-smokers (N=150) were defined as discussed previously, i.e. no next-of-kin reported history and no nicotine or cotinine detected. Differential gene expression analyses were performed as described
above. An ordinal model (non-smoker < light smoker < heavy smoker) was tested to determine whether differentially expressed genes had a dose-response relationship.
Independent cohort replication
Post-mortem DLPFC brain samples from adult patients diagnosed with schizophrenia (N =107, of which 65 were defined as smokers) obtained from the same brain repository, RNA sequenced, preprocessed, and modelled akin to the adult discovery cohort were used as a replication sample. Transcript features, tested in the replication cohort, with the same fold change directionality and nominal significance (p<0.05) as those called differentially expressed (FDR<10%) in the adult non-psychiatric control discovery cohort were considered "replicated".
Gene ontology
All features (genes, exons, exon-exon junctions, and ERs) were mapped to Entrez IDs (76, 77) . This analysis was only performed on the results of the interaction model because it was the only model with enough differentially expressed genes to ensure adequate power for statistical inference. For each ontology, the hypergeometric test for gene ontology (GO) overrepresentation was implemented via the Bioconductor package clusterProfiler independently for each feature type, except "all" which was the union of genes with significant differentially expressed features (78) . As a reference, we used expressed genes (tested for differential expression) which had corresponding Entrez gene IDs. Multiple testing of gene ontology was controlled for with FDR correction. There was not a significant difference (p=0.21) in gene length between the differentially expressed genes (mean length = 4,504bp) and the non-differentially expressed genes (mean length = 4,711bp), therefore gene length is an unlikely source of bias for this analysis.
Targeted gene set enrichment analysis was undertaken using Fisher's exact test of the 2x2 overlap table of differentially expressed genes against all genes present in autism databases AutDB (30) , SFARI Gene (79) , and neuropsychiatric gene sets from Birnbaum et al. (31) . Only expressed genes-tested for differential expression-in our sample were included in the 2x2 contingency table.
Re-analysis of human post-mortem ASD and schizophrenia brain data
We reprocessed sequencing reads from Parikshak et al. (32) using the same RNA-seq pipeline as above, and summarized expressed features relative to Ensembl v75. Within each brain region (BA41-BA42-BA22, BA9, and vermis), we calculated the moderated T-statistics of autism spectrum disorder (ASD) versus control, adjusting for gene assignment rate, brain bank, RIN, age, sex, and quality surrogate variables (80) using limma (69) . The geneSetTest function, also from limma, was used to competitively test whether sets of genes differentially expressed by smoking exposure were differentially expressed by ASD status, separately by brain region.
Schizophrenia differential expression enrichment was assessed analogously as above, using ttests identified in two recent papers using a larger set of RNA-seq data than for the smoking analyses described here (63, 80)
Protein-protein interaction network analysis
Using STRING (v. 10)(33) via the STRINGdb Bioconductor package, gene symbols for differentially expressed, enriched genes were mapped to unique identifiers in the STRING database (STRING score>400, homo sapiens). Functional association networks were then constructed on the basis of corresponding protein-protein interaction scores. For gene sets larger than 400 genes, the maximum number accepted by STRING, the 400 most significant (smallest P-values) genes were used. The p-values at the top of each plot represent the probability of observing an equal or greater number of protein-protein interactions by chance. These p-values were computed via the ppi_enrichment function from the STRINGdb package, and the set of proteins present in the STRING database was used as a background for this calculation (20, 457 proteins, 4,274,001 interactions). The "fastgreedy" algorithm was used to cluster groups within resulting protein-protein interaction networks. Supplemental Table S1 . Demographic and technical characteristics of samples used in this study. Supplemental Table S2 . Prenatal significant differentially expressed NRCAM exon-exon splice junctions. Supplemental Table S3 . Transcript feature summarization results for significant interaction features. Supplemental Table S4 . Enrichment of interaction genes across various ontologies. Supplemental Table S5 . A. Enrichment of differentially expressed prenatal genes in curated gene sets. Supplemental Table S5 . B. Enrichment of interaction genes in curated gene sets.
Supplemental Table S6 . Autism spectrum disorder case-control statistics for differentially expressed prenatal and interaction genes. Table 1 . Significant differentially expressed genes between smoke unexposed and exposed human brain cortices in prenatal and postnatal cohorts (FDR<10%). a False discovery rate.
* NRCAM gene level results presented here. For exon-exon splice junction results see Supplemental Table S2 .
